HA
PBH icon

Harfst & Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Harfst & Associates’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-500
Closed -$27K – 281
2017
Q1 		$27K Buy
+500
New +$27.6K 0.01% 170
2016
Q1 		– Sell
-2,004
Closed -$103K – 192
2015
Q4 		$103K Buy
2,004
+350
+21% +$17.4K 0.04% 133
2015
Q3 		$75K Buy
1,654
+1,558
+1,623% +$73.6K 0.03% 160
2015
Q2 		$4K Buy
+96
New +$4.2K ﹤0.01% 305

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Harfst & Associates's PBH Position: Q2 2017 in Review

Harfst & Associates sold out of Prestige Consumer Healthcare (PBH) in Q2 2017, closing a stake of 500 shares — an estimated $27K sold.

Harfst & Associates first reported a position in PBH in Q2 2015 and held it in 4 quarters. The position peaked at $103K in Q4 2015. 232 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • Harfst & Associates reported no remaining Prestige Consumer Healthcare position as of Q2 2017 after selling out during the quarter.
  • Harfst & Associates sold 500 Prestige Consumer Healthcare shares in Q2 2017, an estimated $27K.
  • Harfst & Associates first reported a position in Prestige Consumer Healthcare in Q2 2015 and held it in 4 quarters.
  • Harfst & Associates's Prestige Consumer Healthcare position peaked at $103K in Q4 2015.
  • 232 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on Harfst & Associates's 13F filing for Q2 2017, filed 11 Aug 2017.